These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37611031)

  • 21. Study of the transcytosis of an anti-transferrin receptor antibody with a Fab' cargo across the blood-brain barrier in mice.
    Manich G; Cabezón I; del Valle J; Duran-Vilaregut J; Camins A; Pallàs M; Pelegrí C; Vilaplana J
    Eur J Pharm Sci; 2013 Jul; 49(4):556-64. PubMed ID: 23748097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.
    Markoutsa E; Pampalakis G; Niarakis A; Romero IA; Weksler B; Couraud PO; Antimisiaris SG
    Eur J Pharm Biopharm; 2011 Feb; 77(2):265-74. PubMed ID: 21118722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single-chain fragment constant design enables easy production of a monovalent blood-brain barrier transporter and provides an improved brain uptake at elevated doses.
    Morrison JI; Metzendorf NG; Rofo F; Petrovic A; Hultqvist G
    J Neurochem; 2023 May; 165(3):413-425. PubMed ID: 36681883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies.
    Eigenmann DE; Xue G; Kim KS; Moses AV; Hamburger M; Oufir M
    Fluids Barriers CNS; 2013 Nov; 10(1):33. PubMed ID: 24262108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional validation of the simplified in vitro 3D Co-culture based BBB model.
    Kim W; Kim J; Lee SY; Kim HM; Jung H; Joo KM; Nam DH
    Biochem Biophys Res Commun; 2022 Oct; 625():128-133. PubMed ID: 35961136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transport of a Prolyl Endopeptidase Inhibitory Peptide across the Blood-Brain Barrier Demonstrated Using the hCMEC/D3 Cell Line Transcytosis Assay.
    Hayes M; Moen LF; Auty MA; Lea TE
    J Agric Food Chem; 2016 Jan; 64(1):146-50. PubMed ID: 26716467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain penetration, target engagement, and disposition of the blood-brain barrier-crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1.
    Webster CI; Caram-Salas N; Haqqani AS; Thom G; Brown L; Rennie K; Yogi A; Costain W; Brunette E; Stanimirovic DB
    FASEB J; 2016 May; 30(5):1927-40. PubMed ID: 26839377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating receptor-mediated antibody transcytosis using blood-brain barrier organoid arrays.
    Simonneau C; Duschmalé M; Gavrilov A; Brandenberg N; Hoehnel S; Ceroni C; Lassalle E; Kassianidou E; Knoetgen H; Niewoehner J; Villaseñor R
    Fluids Barriers CNS; 2021 Sep; 18(1):43. PubMed ID: 34544422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoparticle accumulation and transcytosis in brain endothelial cell layers.
    Ye D; Raghnaill MN; Bramini M; Mahon E; Åberg C; Salvati A; Dawson KA
    Nanoscale; 2013 Nov; 5(22):11153-65. PubMed ID: 24077327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signature Effects of Vector-Guided Systemic Nano Bioconjugate Delivery Across Blood-Brain Barrier of Normal, Alzheimer's, and Tumor Mouse Models.
    Israel LL; Galstyan A; Cox A; Shatalova ES; Sun T; Rashid MH; Grodzinski Z; Chiechi A; Fuchs DT; Patil R; Koronyo-Hamaoui M; Black KL; Ljubimova JY; Holler E
    ACS Nano; 2022 Aug; 16(8):11815-11832. PubMed ID: 35961653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys.
    Kariolis MS; Wells RC; Getz JA; Kwan W; Mahon CS; Tong R; Kim DJ; Srivastava A; Bedard C; Henne KR; Giese T; Assimon VA; Chen X; Zhang Y; Solanoy H; Jenkins K; Sanchez PE; Kane L; Miyamoto T; Chew KS; Pizzo ME; Liang N; Calvert MEK; DeVos SL; Baskaran S; Hall S; Sweeney ZK; Thorne RG; Watts RJ; Dennis MS; Silverman AP; Zuchero YJY
    Sci Transl Med; 2020 May; 12(545):. PubMed ID: 32461332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel human induced pluripotent stem cell blood-brain barrier model: Applicability to study antibody-triggered receptor-mediated transcytosis.
    Ribecco-Lutkiewicz M; Sodja C; Haukenfrers J; Haqqani AS; Ly D; Zachar P; Baumann E; Ball M; Huang J; Rukhlova M; Martina M; Liu Q; Stanimirovic D; Jezierski A; Bani-Yaghoub M
    Sci Rep; 2018 Jan; 8(1):1873. PubMed ID: 29382846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Permeability of PEGylated immunoarsonoliposomes through in vitro blood brain barrier-medulloblastoma co-culture models for brain tumor therapy.
    Al-Shehri A; Favretto ME; Ioannou PV; Romero IA; Couraud PO; Weksler BB; Parker TL; Kallinteri P
    Pharm Res; 2015 Mar; 32(3):1072-83. PubMed ID: 25236341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mathematical PKPD and safety model of bispecific TfR/BACE1 antibodies for the optimization of antibody uptake in brain.
    Gadkar K; Yadav DB; Zuchero JY; Couch JA; Kanodia J; Kenrick MK; Atwal JK; Dennis MS; Prabhu S; Watts RJ; Joseph SB; Ramanujan S
    Eur J Pharm Biopharm; 2016 Apr; 101():53-61. PubMed ID: 26820920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain uptake of multivalent and multi-specific DVD-Ig proteins after systemic administration.
    Karaoglu Hanzatian D; Schwartz A; Gizatullin F; Erickson J; Deng K; Villanueva R; Stedman C; Harris C; Ghayur T; Goodearl A
    MAbs; 2018 Jul; 10(5):765-777. PubMed ID: 29771629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of a Rat Primary Cell-Based Blood-Brain Barrier Model With Epithelial and Brain Endothelial Cell Lines: Gene Expression and Drug Transport.
    Veszelka S; Tóth A; Walter FR; Tóth AE; Gróf I; Mészáros M; Bocsik A; Hellinger É; Vastag M; Rákhely G; Deli MA
    Front Mol Neurosci; 2018; 11():166. PubMed ID: 29872378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Affibody Molecules Intended for Receptor-Mediated Transcytosis via the Transferrin Receptor.
    Hjelm LC; Lindberg H; Ståhl S; Löfblom J
    Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transport across a polarized monolayer of Caco-2 cells by transferrin receptor-mediated adenovirus transcytosis.
    Zhu ZB; Makhija SK; Lu B; Wang M; Rivera AA; Preuss M; Zhou F; Siegal GP; Alvarez RD; Curiel DT
    Virology; 2004 Jul; 325(1):116-28. PubMed ID: 15231391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of in vitro cell-based human blood-brain barrier model using clinical positron emission tomography radioligands to predict in vivo human brain penetration.
    Mabondzo A; Bottlaender M; Guyot AC; Tsaouin K; Deverre JR; Balimane PV
    Mol Pharm; 2010 Oct; 7(5):1805-15. PubMed ID: 20795735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro Blood-Brain barrier model based on recombinant spider silk protein nanomembranes for evaluation of transcytosis capability of biomolecules.
    Hjelm LC; Hedhammar M; Löfblom J
    Biochem Biophys Res Commun; 2023 Aug; 669():77-84. PubMed ID: 37267863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.